Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
Tax Provision
Prestige Consumer Healthcare Inc
Tax Provision Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Tax Provision
-$63.6m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-3%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Tax Provision
-$4.8B
|
CAGR 3-Years
-77%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
0%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Tax Provision
-$554m
|
CAGR 3-Years
20%
|
CAGR 5-Years
18%
|
CAGR 10-Years
-5%
|
|
|
Pfizer Inc
NYSE:PFE
|
Tax Provision
$28m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Tax Provision
-$2.8B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
6%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Tax Provision
-$2.1B
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-13%
|
|
Prestige Consumer Healthcare Inc
Glance View
Prestige Consumer Healthcare Inc. has carved out its niche in the competitive realm of over-the-counter healthcare products with a distinct flair. Born out of a series of insightful acquisitions and strategic brand cultivations, the company has crafted a portfolio that caters to a broad spectrum of consumer health needs. It offers an expansive range of products, from well-known pain relievers and eye care items to gastrointestinal treatments and women’s health solutions. The cornerstone of Prestige's success lies in its acute understanding of consumer demand and its agile response to market trends. By developing and acquiring brands that are established household names—such as Clear Eyes, Chloraseptic, and Dramamine—the firm has effectively secured a reliable revenue stream. Each brand, while under the corporate umbrella of Prestige, thrives on its ability to resonate with consumers who seek trustworthy, easily accessible remedies. Central to Prestige’s business model is its adeptness at maintaining and enhancing brand equity. Through a blend of focused marketing strategies and disciplined cost management, the company ensures consistent visibility and availability of its products across key retail channels, including mass merchandisers, drug retailers, and e-commerce. Prestige's skillful navigation of the marketplace allows it to capitalize on scale economies and maintain healthy margins. Each product in its portfolio is not only a testament to its commitment to quality and efficacy but also to its strategic foresight in addressing the ever-evolving healthcare challenges faced by consumers. In essence, Prestige Consumer Healthcare Inc. thrives by blending astute brand management with a keen focus on consumer health trends, ensuring its position as a formidable player in the healthcare industry.
See Also
What is Prestige Consumer Healthcare Inc's Tax Provision?
Tax Provision
-63.6m
USD
Based on the financial report for Dec 31, 2024, Prestige Consumer Healthcare Inc's Tax Provision amounts to -63.6m USD.
What is Prestige Consumer Healthcare Inc's Tax Provision growth rate?
Tax Provision CAGR 10Y
-3%
The average annual Tax Provision growth rates for Prestige Consumer Healthcare Inc have been -6% over the past three years , and -3% over the past ten years .
You don't have any saved screeners yet